Unlike glucose transporters, LAT1 is regarded as a cancer-specific amino acid transporter with its protein expression predominantly localized to the plasma membrane of cancer cells, which makes LAT1 a promising molecular target for cancer treatment [13]. This evidence concerns the gene SLC38A7 and cancer.